Lasa Supergenerics Limited (LASA.BO)

INR 29.0

(-0.82%)

Total Liabilities Summary of Lasa Supergenerics Limited

  • Lasa Supergenerics Limited's latest annual total liabilities in 2023 was 541.92 Million INR , up 18.92% from previous year.
  • Lasa Supergenerics Limited's latest quarterly total liabilities in 2024 Q1 was -966.76 Million INR , down -278.39% from previous quarter.
  • Lasa Supergenerics Limited reported annual total liabilities of 455.69 Million INR in 2022, down -11.15% from previous year.
  • Lasa Supergenerics Limited reported annual total liabilities of 512.86 Million INR in 2021, up 4.79% from previous year.
  • Lasa Supergenerics Limited reported quarterly total liabilities of 526.29 Million INR for 2023 Q2, down 0.0% from previous quarter.
  • Lasa Supergenerics Limited reported quarterly total liabilities of 541.92 Million INR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Lasa Supergenerics Limited (2023 - 2016)

Historical Annual Total Liabilities of Lasa Supergenerics Limited (2023 - 2016)

Year Total Liabilities Total Liabilities Growth
2023 541.92 Million INR 18.92%
2022 455.69 Million INR -11.15%
2021 512.86 Million INR 4.79%
2020 489.43 Million INR -45.93%
2019 905.23 Million INR -40.91%
2018 1.53 Billion INR -9.59%
2017 1.69 Billion INR 10.92%
2016 1.52 Billion INR 0.0%

Peer Total Liabilities Comparison of Lasa Supergenerics Limited

Name Total Liabilities Total Liabilities Difference
Ajanta Pharma Limited 10.71 Billion INR 94.94%
Amrutanjan Health Care Limited 783.82 Million INR 30.861%
Sigachi Industries Limited 2.53 Billion INR 78.591%
Bal Pharma Limited 2.51 Billion INR 78.42%
Ind-Swift Laboratories Limited 2.28 Billion INR 76.33%
Medico Remedies Limited 438.24 Million INR -23.658%
Venus Remedies Limited 1.39 Billion INR 61.091%
Sun Pharma Advanced Research Company Limited 3.89 Billion INR 86.079%
Alpa Laboratories Limited 307.12 Million INR -76.453%
Nectar Lifesciences Limited 11.21 Billion INR 95.169%
Shilpa Medicare Limited 12.93 Billion INR 95.81%
Aarti Drugs Limited 11.5 Billion INR 95.289%
Lupin Limited 96.23 Billion INR 99.437%
Aurobindo Pharma Limited 152.2 Billion INR 99.644%
Zydus Lifesciences Limited 71.79 Billion INR 99.245%
Windlas Biotech Limited 1.76 Billion INR 69.256%
Suven Life Sciences Limited 148.62 Million INR -264.636%
Eris Lifesciences Limited 38.26 Billion INR 98.584%
Valiant Laboratories Limited 1.05 Billion INR 48.791%
J. B. Chemicals & Pharmaceuticals Limited 10.7 Billion INR 94.939%
Solara Active Pharma Sciences Limited 14.14 Billion INR 96.168%
Ipca Laboratories Limited 33.74 Billion INR 98.394%
Bliss GVS Pharma Limited 2.1 Billion INR 74.302%
Achyut Healthcare Limited 2.01 Million INR -26821.262%
Sun Pharmaceutical Industries Limited 183.56 Billion INR 99.705%
Bajaj HealthCare Limited 4.86 Billion INR 88.867%
RPG Life Sciences Limited 1.38 Billion INR 60.736%
Mankind Pharma Limited 23.87 Billion INR 97.73%
Laurus Labs Limited 42.71 Billion INR 98.731%
Piramal Pharma Limited 74 Billion INR 99.268%
Syncom Formulations (India) Limited 1.16 Billion INR 53.491%
Torrent Pharmaceuticals Limited 82.05 Billion INR 99.34%
Alembic Pharmaceuticals Limited 16.27 Billion INR 96.67%
Glenmark Pharmaceuticals Limited 65.11 Billion INR 99.168%
Unichem Laboratories Limited 8.06 Billion INR 93.284%
Sequent Scientific Limited 8.27 Billion INR 93.45%
Novartis India Limited 1.8 Billion INR 69.911%
Wanbury Limited 3.15 Billion INR 82.826%
Suven Pharmaceuticals Limited 2.03 Billion INR 73.36%
Wockhardt Limited 39.87 Billion INR 98.641%
Themis Medicare Limited 1.88 Billion INR 71.289%
Jagsonpal Pharmaceuticals Limited 296.76 Million INR -82.614%
Jubilant Pharmova Limited 61.27 Billion INR 99.116%
Glenmark Life Sciences Limited 5.18 Billion INR 89.54%
Dr. Reddy's Laboratories Limited 106.96 Billion INR 99.493%
Divi's Laboratories Limited 18.99 Billion INR 97.146%
NATCO Pharma Limited 10.53 Billion INR 94.854%
Gufic Biosciences Limited 5.59 Billion INR 90.322%
IOL Chemicals and Pharmaceuticals Limited 6.32 Billion INR 91.437%
Ind-Swift Limited 13.45 Billion INR 95.972%
Procter & Gamble Health Limited 2.56 Billion INR 78.841%
FDC Limited 3.7 Billion INR 85.39%
Krebs Biochemicals & Industries Limited 2.97 Billion INR 81.777%
Granules India Limited 22.95 Billion INR 97.639%
Medicamen Biotech Limited 940.36 Million INR 42.371%
Alkem Laboratories Limited 48.6 Billion INR 98.885%
AstraZeneca Pharma India Limited 3.66 Billion INR 85.198%
Biofil Chemicals and Pharmaceuticals Limited 288.79 Million INR -87.648%
Brooks Laboratories Limited 248.6 Million INR -117.99%
Megasoft Limited 1.85 Billion INR 70.756%
ZIM Laboratories Limited 2.08 Billion INR 73.955%
Strides Pharma Science Limited 37.68 Billion INR 98.562%
Neuland Laboratories Limited 5.49 Billion INR 90.144%
Morepen Laboratories Limited 4.45 Billion INR 87.849%
Hikal Limited 12.99 Billion INR 95.83%
Indoco Remedies Limited 10.34 Billion INR 94.76%
Aarti Pharmalabs Limited 8.25 Billion INR 93.432%
Kilitch Drugs (India) Limited 643.88 Million INR 15.835%
Mangalam Drugs & Organics Limited 1.97 Billion INR 72.579%
Hester Biosciences Limited 3.59 Billion INR 84.924%